Publicaciones (16) Publicaciones de Alvaro Hernandez Vicente

2024

  1. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 776-784

  2. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial

    Revista Espanola de Cardiologia

2023

  1. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

    Medicina Clinica, Vol. 161, Núm. 5, pp. 185-191

2022

  1. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

    Scientific Reports, Vol. 12, Núm. 1

  2. Critical warm ischemia time point for cardiac donation after circulatory death

    American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328

2021

  1. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction

    Journal of the American College of Cardiology, Vol. 77, Núm. 14, pp. 1747-1759

  2. Colchicine for the treatment of coronary artery disease

    Trends in Cardiovascular Medicine, Vol. 31, Núm. 8, pp. 497-504

  3. Colchicine in recently hospitalized patients with COVID-19: A randomized controlled trial (COL-COVID)

    International Journal of General Medicine, Vol. 14, pp. 5517-5526

2020

  1. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)

    Scientific Reports

  2. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

    Scientific Reports, Vol. 10, Núm. 1

  3. Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure

    European Journal of Internal Medicine, Vol. 77, pp. 66-72

2019

  1. Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure

    Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 315-319

  2. Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 740-748

  3. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure

    Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025

2018

  1. Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology

  2. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population

    International Journal of Cardiology, Vol. 270, pp. 192-196